For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Sagimet Biosciences Inc (NASDAQ: SGMT) closed at $6.05 in the last session, up 0.33% from day before closing price of $6.03. In other words, the price has increased by $0.33 from its previous closing price. On the day, 0.9 million shares were traded. SGMT stock price reached its highest trading level at $6.31 during the session, while it also had its lowest trading level at $5.87.
Ratios:
We take a closer look at SGMT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 13.04 and its Current Ratio is at 13.04. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Wedbush on August 11, 2025, initiated with a Outperform rating and assigned the stock a target price of $28.
On July 24, 2025, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $28.Canaccord Genuity initiated its Buy rating on July 24, 2025, with a $28 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 20 ’25 when Kemble George sold 37,688 shares for $7.69 per share. The transaction valued at 289,979 led to the insider holds 81,005 shares of the business.
GEORGE KEMBLE bought 37,688 shares of SGMT for $295,851 on Nov 20 ’25. On Jul 21 ’25, another insider, Happel David, who serves as the President & CEO of the company, sold 65,478 shares for $9.13 each. As a result, the insider received 598,115 and left with 689,722 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGMT now has a Market Capitalization of 196755680 and an Enterprise Value of 80177672.
Stock Price History:
The Beta on a monthly basis for SGMT is 3.44, which has changed by 0.14857137 over the last 52 weeks, in comparison to a change of 0.16081822 over the same period for the S&P500. Over the past 52 weeks, SGMT has reached a high of $11.41, while it has fallen to a 52-week low of $1.73. The 50-Day Moving Average of the stock is -18.38%, while the 200-Day Moving Average is calculated to be -3.55%.
Shares Statistics:
According to the various share statistics, SGMT traded on average about 560.34K shares per day over the past 3-months and 610730 shares per day over the past 10 days. A total of 31.00M shares are outstanding, with a floating share count of 26.33M. Insiders hold about 19.03% of the company’s shares, while institutions hold 32.77% stake in the company. Shares short for SGMT as of 1764288000 were 3068647 with a Short Ratio of 5.48, compared to 1761868800 on 3127997. Therefore, it implies a Short% of Shares Outstanding of 3068647 and a Short% of Float of 10.6800005.
Earnings Estimates
At present, 8.0 analysts are actively evaluating the performance of Sagimet Biosciences Inc (SGMT) in the stock market.The consensus estimate for the next quarter is -$0.41, with high estimates of -$0.38 and low estimates of -$0.44.
Analysts are recommending an EPS of between -$1.64 and -$1.73 for the fiscal current year, implying an average EPS of -$1.69. EPS for the following year is -$1.91, with 8.0 analysts recommending between -$1.65 and -$2.14.
